7799 — Heron Neutron Medical Balance Sheet
0.000.00%
- TWD98.74bn
- TWD98.17bn
Annual balance sheet for Heron Neutron Medical, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|
Period Length: | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS |
Status: | Final | Final | Final |
Cash | |||
Cash and Equivalents | |||
Short Term Investments | |||
Cash and Short Term Investments | 156 | 233 | 824 |
Net Total Receivables | 7.17 | 6.86 | 1.37 |
Total Inventory | |||
Prepaid Expenses | |||
Total Current Assets | 178 | 262 | 916 |
Gross Property, Plant And Equipment | |||
Accumulated Depreciation | |||
Net Property, Plant And Equipment | 232 | 262 | 589 |
Net Intangible Assets | |||
Other Long Term Assets | |||
Total Assets | 631 | 835 | 1,544 |
Accounts Payable | |||
Notes Payable / Short Term Debt | |||
Current Portion of Long Term Debt / Capital Leases | |||
Total Other Current Liabilities | |||
Total Current Liabilities | 27.2 | 19.2 | 44.3 |
Capital Lease Obligations | |||
Total Long Term Debt | |||
Total Debt | |||
Total Other Liabilities | |||
Total Liabilities | 40.6 | 28.7 | 72 |
Common Stock | |||
Additional Paid In Capital | |||
Retained Earnings (Accumulated Deficit) | |||
Total Equity | 590 | 806 | 1,472 |
Total Liabilities & Shareholders' Equity | 631 | 835 | 1,544 |
Total Common Shares Outstanding |